Stallergenes Greer: Rhinitis, Allergic trials
The registry lists 15 Rhinitis, Allergic studies with Stallergenes Greer as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 1 4Phase 2 3Phase 3 6No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated ARCompletedNCT02443805Phase 3Results posted
- Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in AdolescentsCompletedNCT01919554Phase 1Results posted
- Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber ModelCompletedNCT01527188Phase 2Results posted
- Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and ChildrenTerminatedNCT01199133Phase 3Results posted
- Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen RhinoconjunctivitisCompletedNCT00955825Phase 3Results posted
- Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic RhinitisCompletedNCT00674700Phase 2/3Results posted
- Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen ExtractCompletedNCT00619827Phase 1Results posted
- Efficacy Study of Sublingual Immunotherapy to Treat Ragweed AllergiesCompletedNCT00599872Phase 3Results posted
- Evaluation of the Benefits of Sublingual AIT (PRACTIS)CompletedNCT06574061
- Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without ConjunctivitisCompletedNCT02295969
- International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic RhinitisTerminatedNCT02041624
- Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic RhinoconjunctivitisCompletedNCT01731249Phase 3
- Study of rBet v1 TabletsCompletedNCT00901914Phase 2
- Safety and Tolerability Study of rBet v1 SLIT TabletsCompletedNCT00889460Phase 1
- Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1CompletedNCT00396149Phase 1